Slingshot members are tracking this event:
Phase 2 Open-Label Extension Study of EN3835 in the Treatment of Cellulite expected to be complete in June 2018
Slingshot Insights Explained
Oct 18, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Edematous Fibrosclerotic Panniculopathy, Cellulite